Intrinsic value of Inovalon Holdings Cl A - INOV

Previous Close

$11.01

  Intrinsic Value

$15.22

stock screener

  Rating & Target

buy

+38%

Previous close

$11.01

 
Intrinsic value

$15.22

 
Up/down potential

+38%

 
Rating

buy

We calculate the intrinsic value of INOV stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.8

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  38.20
  34.88
  31.89
  29.20
  26.78
  24.60
  22.64
  20.88
  19.29
  17.86
  16.58
  15.42
  14.38
  13.44
  12.60
  11.84
  11.15
  10.54
  9.98
  9.48
  9.04
  8.63
  8.27
  7.94
  7.65
  7.38
  7.15
  6.93
  6.74
  6.56
Revenue, $m
  621
  838
  1,105
  1,427
  1,810
  2,255
  2,766
  3,343
  3,988
  4,700
  5,479
  6,324
  7,233
  8,205
  9,239
  10,332
  11,485
  12,695
  13,962
  15,286
  16,668
  18,106
  19,604
  21,161
  22,779
  24,461
  26,209
  28,025
  29,914
  31,877
Variable operating expenses, $m
  555
  739
  966
  1,241
  1,566
  1,944
  2,378
  2,869
  3,417
  4,022
  4,657
  5,375
  6,148
  6,974
  7,853
  8,782
  9,762
  10,790
  11,867
  12,993
  14,167
  15,390
  16,663
  17,986
  19,362
  20,791
  22,277
  23,821
  25,426
  27,094
Fixed operating expenses, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  555
  739
  966
  1,241
  1,566
  1,944
  2,378
  2,869
  3,417
  4,022
  4,657
  5,375
  6,148
  6,974
  7,853
  8,782
  9,762
  10,790
  11,867
  12,993
  14,167
  15,390
  16,663
  17,986
  19,362
  20,791
  22,277
  23,821
  25,426
  27,094
Operating income, $m
  66
  98
  138
  187
  244
  311
  387
  474
  571
  678
  822
  949
  1,085
  1,231
  1,386
  1,550
  1,723
  1,905
  2,095
  2,293
  2,501
  2,717
  2,941
  3,175
  3,418
  3,670
  3,932
  4,205
  4,488
  4,783
EBITDA, $m
  140
  188
  248
  321
  407
  507
  622
  751
  896
  1,056
  1,231
  1,421
  1,626
  1,844
  2,076
  2,322
  2,581
  2,853
  3,138
  3,436
  3,746
  4,070
  4,406
  4,756
  5,120
  5,498
  5,891
  6,299
  6,723
  7,165
Interest expense (income), $m
  5
  13
  20
  28
  38
  49
  64
  80
  99
  120
  144
  170
  199
  230
  264
  299
  338
  378
  420
  465
  512
  561
  612
  665
  720
  777
  837
  899
  964
  1,031
  1,100
Earnings before tax, $m
  52
  78
  111
  149
  195
  247
  307
  375
  451
  534
  652
  750
  855
  967
  1,087
  1,213
  1,345
  1,484
  1,630
  1,782
  1,940
  2,105
  2,277
  2,455
  2,640
  2,833
  3,033
  3,241
  3,458
  3,682
Tax expense, $m
  14
  21
  30
  40
  53
  67
  83
  101
  122
  144
  176
  202
  231
  261
  293
  327
  363
  401
  440
  481
  524
  568
  615
  663
  713
  765
  819
  875
  934
  994
Net income, $m
  38
  57
  81
  109
  142
  181
  224
  274
  329
  390
  476
  547
  624
  706
  793
  885
  982
  1,083
  1,190
  1,301
  1,416
  1,537
  1,662
  1,792
  1,927
  2,068
  2,214
  2,366
  2,524
  2,688

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  824
  1,111
  1,465
  1,893
  2,400
  2,991
  3,668
  4,434
  5,289
  6,234
  7,267
  8,387
  9,593
  10,882
  12,253
  13,703
  15,232
  16,836
  18,517
  20,274
  22,106
  24,014
  26,000
  28,065
  30,211
  32,442
  34,760
  37,169
  39,673
  42,277
Adjusted assets (=assets-cash), $m
  824
  1,111
  1,465
  1,893
  2,400
  2,991
  3,668
  4,434
  5,289
  6,234
  7,267
  8,387
  9,593
  10,882
  12,253
  13,703
  15,232
  16,836
  18,517
  20,274
  22,106
  24,014
  26,000
  28,065
  30,211
  32,442
  34,760
  37,169
  39,673
  42,277
Revenue / Adjusted assets
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
  0.754
Average production assets, $m
  334
  451
  594
  768
  974
  1,213
  1,488
  1,799
  2,145
  2,529
  2,948
  3,402
  3,892
  4,414
  4,971
  5,559
  6,179
  6,830
  7,512
  8,224
  8,967
  9,741
  10,547
  11,385
  12,255
  13,160
  14,100
  15,078
  16,093
  17,150
Working capital, $m
  50
  67
  88
  114
  145
  180
  221
  267
  319
  376
  438
  506
  579
  656
  739
  827
  919
  1,016
  1,117
  1,223
  1,333
  1,449
  1,568
  1,693
  1,822
  1,957
  2,097
  2,242
  2,393
  2,550
Total debt, $m
  366
  514
  696
  917
  1,178
  1,482
  1,831
  2,225
  2,666
  3,152
  3,684
  4,261
  4,882
  5,546
  6,252
  6,999
  7,786
  8,613
  9,478
  10,383
  11,326
  12,309
  13,332
  14,395
  15,501
  16,649
  17,843
  19,084
  20,373
  21,714
Total liabilities, $m
  424
  572
  755
  975
  1,236
  1,540
  1,889
  2,283
  2,724
  3,210
  3,742
  4,320
  4,941
  5,604
  6,310
  7,057
  7,844
  8,671
  9,536
  10,441
  11,384
  12,367
  13,390
  14,453
  15,559
  16,708
  17,901
  19,142
  20,432
  21,773
Total equity, $m
  399
  539
  711
  918
  1,164
  1,450
  1,779
  2,150
  2,565
  3,023
  3,524
  4,068
  4,653
  5,278
  5,943
  6,646
  7,387
  8,166
  8,981
  9,833
  10,721
  11,647
  12,610
  13,611
  14,652
  15,734
  16,859
  18,027
  19,241
  20,504
Total liabilities and equity, $m
  823
  1,111
  1,466
  1,893
  2,400
  2,990
  3,668
  4,433
  5,289
  6,233
  7,266
  8,388
  9,594
  10,882
  12,253
  13,703
  15,231
  16,837
  18,517
  20,274
  22,105
  24,014
  26,000
  28,064
  30,211
  32,442
  34,760
  37,169
  39,673
  42,277
Debt-to-equity ratio
  0.920
  0.950
  0.980
  1.000
  1.010
  1.020
  1.030
  1.030
  1.040
  1.040
  1.050
  1.050
  1.050
  1.050
  1.050
  1.050
  1.050
  1.050
  1.060
  1.060
  1.060
  1.060
  1.060
  1.060
  1.060
  1.060
  1.060
  1.060
  1.060
  1.060
Adjusted equity ratio
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485
  0.485

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  38
  57
  81
  109
  142
  181
  224
  274
  329
  390
  476
  547
  624
  706
  793
  885
  982
  1,083
  1,190
  1,301
  1,416
  1,537
  1,662
  1,792
  1,927
  2,068
  2,214
  2,366
  2,524
  2,688
Depreciation, amort., depletion, $m
  74
  90
  110
  134
  163
  196
  234
  277
  325
  379
  409
  473
  540
  613
  690
  772
  858
  949
  1,043
  1,142
  1,245
  1,353
  1,465
  1,581
  1,702
  1,828
  1,958
  2,094
  2,235
  2,382
Funds from operations, $m
  112
  147
  191
  243
  305
  376
  459
  551
  654
  768
  885
  1,020
  1,165
  1,319
  1,484
  1,657
  1,840
  2,032
  2,233
  2,443
  2,662
  2,890
  3,127
  3,373
  3,630
  3,896
  4,173
  4,460
  4,759
  5,070
Change in working capital, $m
  14
  17
  21
  26
  31
  36
  41
  46
  52
  57
  62
  68
  73
  78
  83
  87
  92
  97
  101
  106
  111
  115
  120
  125
  129
  135
  140
  145
  151
  157
Cash from operations, $m
  98
  130
  169
  217
  274
  341
  418
  505
  603
  711
  823
  952
  1,092
  1,242
  1,401
  1,570
  1,748
  1,935
  2,132
  2,337
  2,551
  2,774
  3,007
  3,249
  3,500
  3,761
  4,033
  4,315
  4,608
  4,913
Maintenance CAPEX, $m
  -34
  -46
  -63
  -83
  -107
  -135
  -168
  -207
  -250
  -298
  -351
  -409
  -473
  -540
  -613
  -690
  -772
  -858
  -949
  -1,043
  -1,142
  -1,245
  -1,353
  -1,465
  -1,581
  -1,702
  -1,828
  -1,958
  -2,094
  -2,235
New CAPEX, $m
  -92
  -117
  -144
  -174
  -206
  -240
  -275
  -311
  -347
  -383
  -419
  -455
  -489
  -523
  -556
  -588
  -620
  -651
  -682
  -712
  -743
  -774
  -806
  -838
  -871
  -905
  -940
  -977
  -1,016
  -1,056
Cash from investing activities, $m
  -126
  -163
  -207
  -257
  -313
  -375
  -443
  -518
  -597
  -681
  -770
  -864
  -962
  -1,063
  -1,169
  -1,278
  -1,392
  -1,509
  -1,631
  -1,755
  -1,885
  -2,019
  -2,159
  -2,303
  -2,452
  -2,607
  -2,768
  -2,935
  -3,110
  -3,291
Free cash flow, $m
  -28
  -33
  -37
  -39
  -38
  -34
  -26
  -12
  6
  30
  53
  88
  130
  178
  232
  291
  356
  426
  501
  581
  666
  755
  848
  946
  1,048
  1,154
  1,265
  1,379
  1,498
  1,621
Issuance/(repayment) of debt, $m
  117
  148
  182
  220
  261
  304
  349
  394
  440
  487
  532
  577
  621
  664
  706
  747
  787
  827
  866
  905
  943
  983
  1,023
  1,063
  1,105
  1,149
  1,194
  1,241
  1,290
  1,341
Issuance/(repurchase) of shares, $m
  73
  82
  91
  99
  104
  106
  104
  97
  86
  69
  25
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  190
  230
  273
  319
  365
  410
  453
  491
  526
  556
  557
  577
  621
  664
  706
  747
  787
  827
  866
  905
  943
  983
  1,023
  1,063
  1,105
  1,149
  1,194
  1,241
  1,290
  1,341
Total cash flow (excl. dividends), $m
  162
  197
  237
  280
  327
  376
  427
  480
  532
  585
  610
  665
  751
  842
  938
  1,038
  1,143
  1,253
  1,367
  1,486
  1,609
  1,738
  1,871
  2,010
  2,154
  2,303
  2,458
  2,620
  2,788
  2,963
Retained Cash Flow (-), $m
  -111
  -139
  -172
  -208
  -246
  -286
  -328
  -371
  -415
  -458
  -501
  -543
  -585
  -625
  -665
  -703
  -741
  -778
  -815
  -852
  -889
  -926
  -963
  -1,002
  -1,041
  -1,082
  -1,124
  -1,168
  -1,215
  -1,263
Prev. year cash balance distribution, $m
  354
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  405
  58
  65
  73
  81
  90
  99
  108
  118
  127
  109
  122
  166
  217
  273
  335
  402
  474
  552
  634
  721
  812
  908
  1,008
  1,113
  1,221
  1,334
  1,452
  1,573
  1,700
Discount rate, %
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
  389
  53
  56
  60
  63
  65
  67
  68
  68
  67
  52
  52
  63
  73
  80
  85
  87
  87
  85
  81
  75
  67
  60
  51
  43
  36
  29
  22
  17
  13
Current shareholders' claim on cash, %
  83.0
  71.1
  62.5
  56.1
  51.4
  47.9
  45.2
  43.3
  41.9
  41.0
  40.7
  40.7
  40.7
  40.7
  40.7
  40.7
  40.7
  40.7
  40.7
  40.7
  40.7
  40.7
  40.7
  40.7
  40.7
  40.7
  40.7
  40.7
  40.7
  40.7

Inovalon Holdings, Inc. (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem. The Company serves clients across the healthcare industry, which includes health plans and provider organizations, pharmaceutical, medical device, and diagnostics companies. It provides technology that supports approximately 500 healthcare organizations. Inovalon's platforms are informed by data pertaining to more than 858,000 physicians, 377,000 clinical facilities, and more than 230 million Americans.

FINANCIAL RATIOS  of  Inovalon Holdings Cl A (INOV)

Valuation Ratios
P/E Ratio 60.4
Price to Sales 3.8
Price to Book 2.4
Price to Tangible Book
Price to Cash Flow 17.5
Price to Free Cash Flow 30.2
Growth Rates
Sales Growth Rate -2.1%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 50%
Cap. Spend. - 3 Yr. Gr. Rate 15.5%
Financial Strength
Quick Ratio 19
Current Ratio 0
LT Debt to Equity 34.6%
Total Debt to Equity 39%
Interest Coverage 9
Management Effectiveness
Return On Assets 2.8%
Ret/ On Assets - 3 Yr. Avg. 11.1%
Return On Total Capital 2.7%
Ret/ On T. Cap. - 3 Yr. Avg. 12.5%
Return On Equity 3.8%
Return On Equity - 3 Yr. Avg. 26.6%
Asset Turnover 0.4
Profitability Ratios
Gross Margin 62.6%
Gross Margin - 3 Yr. Avg. 66%
EBITDA Margin 18.9%
EBITDA Margin - 3 Yr. Avg. 28.9%
Operating Margin 8.9%
Oper. Margin - 3 Yr. Avg. 22%
Pre-Tax Margin 9.1%
Pre-Tax Margin - 3 Yr. Avg. 21.8%
Net Profit Margin 6.3%
Net Profit Margin - 3 Yr. Avg. 13.1%
Effective Tax Rate 30.8%
Eff/ Tax Rate - 3 Yr. Avg. 37.9%
Payout Ratio 0%

INOV stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the INOV stock intrinsic value calculation we used $449.358 million for the last fiscal year's total revenue generated by Inovalon Holdings Cl A. The default revenue input number comes from 0001 income statement of Inovalon Holdings Cl A. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our INOV stock valuation model: a) initial revenue growth rate of 38.2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for INOV is calculated based on our internal credit rating of Inovalon Holdings Cl A, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Inovalon Holdings Cl A.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of INOV stock the variable cost ratio is equal to 91.1%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for INOV stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Inovalon Holdings Cl A.

Corporate tax rate of 27% is the nominal tax rate for Inovalon Holdings Cl A. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the INOV stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for INOV are equal to 53.8%.

Life of production assets of 7.2 years is the average useful life of capital assets used in Inovalon Holdings Cl A operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for INOV is equal to 8%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $642.772 million for Inovalon Holdings Cl A - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 71.66 million for Inovalon Holdings Cl A is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Inovalon Holdings Cl A at the current share price and the inputted number of shares is $0.8 billion.

RELATED COMPANIES Price Int.Val. Rating
HSTM HealthStream 24.81 11.58  str.sell
NH NantHealth 1.43 0.02  str.sell
MCK McKesson 130.15 340.66  str.buy
IBM International 120.84 191.80  buy
VEEV Veeva Systems 90.52 49.34  sell
CERN Cerner 56.41 29.77  str.sell
UNH UnitedHealth G 269.22 561.84  str.buy

COMPANY NEWS

▶ Inovalon Announces 2018 Investor Day   [Nov-13-18 07:55AM  GlobeNewswire]
▶ Inovalon Holdings: 3Q Earnings Snapshot   [07:13PM  Associated Press]
▶ Inovalon Reports Third Quarter 2018 Results   [04:10PM  GlobeNewswire]
▶ ABILITY Network Announces the 2018 HomeCare Elite   [Oct-08-18 10:00AM  GlobeNewswire]
▶ Inovalon Holdings: 2Q Earnings Snapshot   [05:42PM  Associated Press]
▶ Inovalon Reports Second Quarter 2018 Results   [04:15PM  GlobeNewswire]
▶ Md. health IT firm expects major revenue bump with Walgreens deal   [Jun-27-18 05:59PM  American City Business Journals]
▶ Inovalon to close Columbia office, lay off 70 people   [Jun-20-18 01:22PM  American City Business Journals]
▶ Inovalon Holdings: 1Q Earnings Snapshot   [May-08-18 06:36PM  Associated Press]
▶ Inovalon Reports First Quarter 2018 Results   [04:10PM  GlobeNewswire]
▶ Health IT firm Ability Network to be sold for $1.2B   [Mar-07-18 04:52PM  American City Business Journals]
▶ [$$] Inovalon to Buy Ability Network for $1.2 Billion   [04:28PM  The Wall Street Journal]
▶ Inovalon enters $1.2B deal to acquire Minneapolis health IT company   [08:45AM  American City Business Journals]
▶ Inovalon to Acquire ABILITY Network   [07:00AM  GlobeNewswire]
▶ Inovalon Holdings misses 4Q profit forecasts   [05:02AM  Associated Press]
▶ Inovalon Reports Fourth Quarter and Full Year 2017 Results   [Feb-20-18 04:10PM  GlobeNewswire]
▶ Inovalon Announces Charitable Giving for 2017   [Jan-03-18 07:55AM  GlobeNewswire]
▶ Inovalon Holdings tops Street 3Q forecasts   [05:49AM  Associated Press]
▶ Inovalon Reports Third Quarter 2017 Results   [Nov-01-17 04:10PM  GlobeNewswire]
▶ What Happened in the Stock Market Today   [Sep-12-17 05:00PM  Motley Fool]
▶ Why Shares of Inovalon Are Soaring Today   [12:58PM  Motley Fool]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.